Oceanpine Capital has closed a new RMB-denominated fund at 2 billion yuan ($313.4 million) as it seeks to up the ante on deep technology investments. The fund was closed within three months of its launch. The new vehicle secured commitments from local government-guided funds, funds of funds (FOFs), and deep tech companies. It has already collected 30% of committed capital, or 600 million yuan ($93.7 million), from its limited partners (LPs) and started making investments.
The development marks another fundraising success for Beijing-based Oceanpine. In December 2020, the firm held the final close for its second fund at $400 million after raising external capital for the first time. The US dollar-denominated fund will make investments in deep tech, technology, media, and telecom (TMT), and biotech companies in China.
Oceanpine’s maiden US dollar fund was launched in 2016 with a $400-million capital pool and was fully funded by the general partner.
Oceanpine, an investor in JD.com’s fintech affiliate JD Digits and China’s Tencent Music Entertainment Group, has joined a small group of China-focused private equity (PE) fund managers that have raised large-sized funds despite a regional market downturn.
A report by consultancy Bain shows that fundraising activity in Asia declined for the third consecutive year in 2020. Asia-focused funds collectively raised $90 billion last year, 65% lower than a peak in 2017. However, top-notch PE companies’ fundraising plans remain on track as risk-averse LPs entrust more of their money to players with the best track records.
Oceanpine was formally launched in 2018, it is a growth equity investment firm that manages dual-currency funds to primarily invest in deep technologies across the TMT and healthcare industries. It specialises in segments ranging from artificial intelligence (AI), semiconductor, autonomous driving, 5G, Internet of Things (IoT), and corporate services to big data, cloud computing, cybersecurity, industrial internet, new energy, and novel drug R&D.
Oceanpine Capital will continue its strategy of focusing its firepower on China, searching for entrepreneurs who have the potential to grow businesses on a global scale. “We firmly believe that we are at the golden era for entrepreneurship opportunities around deep technology and China’s third-generation of new economy development.”
Over the last three years, Oceanpine claims to have deployed over $2 billion in more than 50 deep technology companies in China and the US.
Prominent portfolio companies include Chinese ride-hailing giant Didi Chuxing; AI computing-power specialist Enflame Technology; biotech firm Ansun Biopharma; AI chip designer Horizon Robotics; AI startup Black Sesame; US-based graphical database platform TigerGraph; and Clover Biopharmaceuticals, a clinical-stage biotech firm developing COVID-19 and other novel vaccines. It has also secured several exits, including nearly 10 IPOs.
Oceanpine Capital also manages USD-denominated funds in the PE secondary market, which involves the buying and selling of pre-existing investor commitments to PE or other alternative investment funds.
Source: Oceanpine Capital
